Jane Street Group, LLC Protagonist Therapeutics, Inc Call Options Transaction History

Jane Street Group, LLC

  • $616 Billion
  • Q3 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$49.7 - $67.42 $273,350 - $370,810
5,500 Added 27.09%
25,800 $1.71 Million
Q2 2025

Aug 14, 2025
SELL
$40.89 - $56.37 $3.3 Million - $4.55 Million
-80,700 Reduced 79.9%
20,300 $1.12 Million
Q1 2025

May 14, 2025
BUY
$35.09 - $59.76 $3.54 Million - $6.04 Million
101,000 New
101,000 $4.88 Million
Q4 2021

Feb 15, 2022
BUY
$17.63 - $37.1 $675,229 - $1.42 Million
38,300 New
38,300 $1.31 Million

Others Institutions Holding PTGX

# of Institutions
294
Shares Held
66.9M
Call Options Held
139K
Put Options Held
40.7K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $4.15B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email